Available to sourceHuman Prescription DrugOncology & Specialty

Litfulo (ritlecitinib)

Active ingredients · Ritlecitinib Tosylate

50 mg/1 · Capsule

By U.S. Pharmaceuticals

NDC: 63539-334
Route: Oral
Therapeutic class: Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Janus Kinase 3 Inhibitors [MoA], Kinase Inhibitor , Tyrosine Kinase Inhibitors [MoA]
Marketing category: NDA

Package sizes

28 CAPSULE in 1 BOTTLE (63539-334-28)NDC 63539-334-28Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Oncology & Specialty

See all →

Litfulo (ritlecitinib)

Package sizes

Additional information

Request this medication

Related in Oncology & Specialty

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)